Oxford Biomedica annual gross margin
2020
2021
2022
2023
2024
2025
Oxford Biomedica Gross Margin Growth & History (OXB)
Oxford Biomedica's gross margin was 39.10% for fiscal 2025.
View full Oxford Biomedica company overviewOxford Biomedica annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 39.10% | −2.06 pp |
| 2024 | 2024-12-31 | 41.17% | −3.20 pp |
| 2023 | 2023-12-31 | 44.37% | −5.05 pp |
| 2022 | 2022-12-31 | 49.42% | −8.45 pp |
| 2021 | 2021-12-31 | 57.87% | +5.35 pp |
| 2020 | 2020-12-31 | 52.52% | — |
Oxford Biomedica gross margin trends
Over the last five fiscal years, Oxford Biomedica's gross margin decreased from 52.52% to 39.10%, a change of −13.42 percentage points.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as reported gross profit divided by reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Oxford Biomedica source filings ↗